Log In
Print
BCIQ
Print
Print this Print this
 

OpRegen

  Manage Alerts
Collapse Summary General Information
Company BioTime Inc.
DescriptionHuman embryonic stem cell derived retinal pigmented epithelial (RPE) cells
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat geographic atrophy (GA) associated with dry or non-neovascular age-related macular degeneration (AMD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today